跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

Bacteriochlorophyll A

首页药物Bacteriochlorophyll A

Experimental

Small Molecule

Bacteriochlorophyll A

未知生产厂商

A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.

生成 AI 研报

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.

技术标识符

化学式: C₅₅H₇₄MgN₄O₆
CAS 编号: 17499-98-8

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Water-soluble anionic bacteriochlorophyll derivatives and their uses
US 7947672 B2申请人: YEDA RES & DEV优先权: 2002
CN
EP
US
8 件公开
Catatonic bacteriochlorophyll derivatives
US 8207154 B2申请人: SCHERZ AVIGDOR优先权: 2004
CN
EP
US
WO
6 件公开
Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
US 11278555 B2申请人: YEDA RES & DEV优先权: 2016
CN
US
2 件公开
Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives
US 7045117 B2申请人: YEDA RES & DEV优先权: 2003
US
2 件公开
Green sulfur bacteria variant and bacteriochlorophyll
US 9586971 B2申请人: UNIV KURUME优先权: 2012
US
2 件公开
Palladium-substituted bacteriochlorophyll derivatives and use thereof
US 6569846 B1申请人: YEDA RES & DEV优先权: 1998
US
Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US 6740637 B1申请人: YEDA RES & DEV优先权: 2000
US
COSMETIC COMPOSITION COMPRISING BACTERIOCHLOROPHYLL-CONTAINING MICROBIAL CELL PIECE AS ACTIVE INGREDIENT
WO 2014109426 A1申请人: DOOSAN ECOBIZNET CO LTD优先权: 2013
WO
Methods for preparing bacteriopheophytin a and esters of bacteriopheophytin a
CN 108341827 A申请人: ZHEJIANG HISUN PHARM CO LTD优先权: 2018
CN
Combination therapies for treatment of cancer
US 10933134 B2申请人: MEMORIAL SLOAN KETTERING CANCER CENTER优先权: 2018
US

第 1 / 2 页